STAAR Surgical
Yahoo Finance • 8 months ago
STAAR Surgical to Report First Quarter Results on May 7, 2024
LAKE FOREST, Calif., April 29, 2024--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia... Full story
Yahoo Finance • last year
Lilian Zhou Appointed to STAAR Surgical Board of Directors
LAKE FOREST, Calif., December 04, 2023--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia,... Full story
Yahoo Finance • last year
Should Weakness in STAAR Surgical Company's (NASDAQ:STAA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
With its stock down 18% over the past month, it is easy to disregard STAAR Surgical (NASDAQ:STAA). However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Spe... Full story
Yahoo Finance • 2 years ago
15 Largest Ophthalmology Companies in the World
In this article, we will take a look at the 15 largest ophthalmology companies in the world. If you want to see more companies in this selection, go to the 5 Largest Ophthalmology Companies in the World. The ophthalmology industry encompa... Full story
Yahoo Finance • 2 years ago
STAAR Surgical to Report Third Quarter Results on November 2, 2022
LAKE FOREST, Calif., October 19, 2022--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will re... Full story
Yahoo Finance • 2 years ago
3 Winning Evergreen Stocks to Buy and Hold for the Next 25 Years
Vertex Pharmaceuticals (NASDAQ: VRTX) is an evergreen stock because it has proven that it's an expert at consistently extracting wild growth from a tiny niche. Of the 83,000 estimated patients living with the rare hereditary disease cystic... Full story
Yahoo Finance • 3 years ago
STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y
EVO Visian® ICL Lenses Received FDA Approval and First Lenses Implanted LAKE FOREST, Calif., May 04, 2022--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and co... Full story
Yahoo Finance • 3 years ago
Stock Market Trades Lower As Biden Announces Defense, Budget Plan
Stock market trades lower as President Biden unveils a new budget plan, which calls for a substantial increase in defense spending.... Full story
Yahoo Finance • 3 years ago
Tesla Plans Another Stock Split, but This Tiny Nasdaq Stock Jumped Even More
The stock market has been in recovery mode for the last several weeks, and signs pointed to continued modest gains for major market benchmarks. As of 7:30 a.m. ET, futures on the Nasdaq Composite (NASDAQINDEX: ^IXIC) were up 14 points to 1... Full story
